Huadong Operating Income vs Gross Profit Analysis

000963 Stock

35.95 0.24 0.66%

Huadong Medicine financial indicator trend analysis is much more than just examining Huadong Medicine latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Huadong Medicine is a good investment. Please check the relationship between Huadong Medicine Operating Income and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Huadong Medicine Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Operating Income vs Gross Profit

Operating Income vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Huadong Medicine Operating Income account and Gross Profit. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Huadong Medicine's Operating Income and Gross Profit is 0.92. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Huadong Medicine Co, assuming nothing else is changed. The correlation between historical values of Huadong Medicine's Operating Income and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Huadong Medicine Co are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Operating Income i.e., Huadong Medicine's Operating Income and Gross Profit go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Huadong Medicine operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Huadong Medicine Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Huadong Medicine Co minus its cost of goods sold. It is profit before Huadong Medicine operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Huadong Medicine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Huadong Medicine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Huadong Medicine Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of December 23, 2024, Selling General Administrative is expected to decline to about 2.8 B. In addition to that, Tax Provision is expected to decline to about 543.9 M

	2021	2022	2023	2024 (projected)
Operating Income	3.0B	3.3B	3.8B	4.0B
Total Revenue	34.6B	37.7B	40.6B	42.7B

Operating Income Total Revenue

Huadong Medicine fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Good Will	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.3	0.96	0.99	0.93	0.98	0.97	0.98	0.94	0.93	0.89	0.94	0.17	0.96	0.97	0.95	0.99	0.26	0.94	0.91	-0.75	0.9	0.84	0.95	0.84	0.91
Other Current Liab	0.3		0.34	0.26	0.17	0.23	0.32	0.27	0.19	0.45	0.37	0.49	0.87	0.36	0.15	0.32	0.28	0.25	0.22	0.44	-0.13	0.28	0.55	0.36	0.51	0.3
Total Current Liabilities	0.96	0.34		0.92	0.85	0.92	0.97	0.92	0.88	0.95	0.81	0.93	0.26	0.99	0.9	0.9	0.95	0.3	0.87	0.82	-0.7	0.82	0.76	0.86	0.76	0.83
Total Stockholder Equity	0.99	0.26	0.92		0.94	0.99	0.93	0.98	0.95	0.9	0.9	0.91	0.1	0.91	0.97	0.96	0.99	0.18	0.96	0.93	-0.77	0.92	0.86	0.97	0.85	0.92
Other Liab	0.93	0.17	0.85	0.94		0.95	0.85	0.91	0.94	0.79	0.83	0.8	0.01	0.85	0.98	0.9	0.91	0.15	0.98	0.82	-0.67	0.86	0.75	0.9	0.75	0.92
Retained Earnings	0.98	0.23	0.92	0.99	0.95		0.91	0.96	0.98	0.86	0.87	0.88	0.06	0.91	0.98	0.96	0.99	0.12	0.97	0.91	-0.79	0.89	0.84	0.95	0.8	0.94
Accounts Payable	0.97	0.32	0.97	0.93	0.85	0.91		0.95	0.85	0.97	0.84	0.96	0.27	0.98	0.91	0.89	0.93	0.41	0.86	0.84	-0.66	0.85	0.74	0.89	0.81	0.81
Cash	0.98	0.27	0.92	0.98	0.91	0.96	0.95		0.93	0.92	0.87	0.92	0.12	0.93	0.94	0.91	0.96	0.3	0.9	0.91	-0.69	0.88	0.83	0.94	0.84	0.87
Other Assets	0.94	0.19	0.88	0.95	0.94	0.98	0.85	0.93		0.78	0.78	0.79	-0.02	0.86	0.96	0.89	0.95	0.07	0.95	0.86	-0.78	0.82	0.82	0.9	0.71	0.93
Net Receivables	0.93	0.45	0.95	0.9	0.79	0.86	0.97	0.92	0.78		0.87	0.99	0.37	0.96	0.83	0.89	0.9	0.4	0.81	0.85	-0.61	0.85	0.78	0.87	0.86	0.76
Short Term Investments	0.89	0.37	0.81	0.9	0.83	0.87	0.84	0.87	0.78	0.87		0.91	0.2	0.81	0.84	0.94	0.88	0.25	0.85	0.89	-0.74	0.92	0.83	0.91	0.88	0.8
Inventory	0.94	0.49	0.93	0.91	0.8	0.88	0.96	0.92	0.79	0.99	0.91		0.4	0.94	0.84	0.91	0.91	0.39	0.83	0.89	-0.67	0.88	0.83	0.9	0.9	0.79
Other Current Assets	0.17	0.87	0.26	0.1	0.01	0.06	0.27	0.12	-0.02	0.37	0.2	0.4		0.31	0.02	0.15	0.13	0.49	0.07	0.24	0.07	0.12	0.29	0.19	0.36	0.13
Total Liab	0.96	0.36	0.99	0.91	0.85	0.91	0.98	0.93	0.86	0.96	0.81	0.94	0.31		0.9	0.88	0.93	0.42	0.86	0.81	-0.65	0.81	0.74	0.86	0.77	0.82
Intangible Assets	0.97	0.15	0.9	0.97	0.98	0.98	0.91	0.94	0.96	0.83	0.84	0.84	0.02	0.9		0.93	0.96	0.18	0.98	0.85	-0.72	0.87	0.75	0.93	0.76	0.93
Common Stock	0.95	0.32	0.9	0.96	0.9	0.96	0.89	0.91	0.89	0.89	0.94	0.91	0.15	0.88	0.93		0.96	0.08	0.95	0.91	-0.82	0.94	0.87	0.93	0.87	0.9
Property Plant Equipment	0.99	0.28	0.95	0.99	0.91	0.99	0.93	0.96	0.95	0.9	0.88	0.91	0.13	0.93	0.96	0.96		0.13	0.95	0.91	-0.81	0.89	0.86	0.94	0.82	0.92
Long Term Debt	0.26	0.25	0.3	0.18	0.15	0.12	0.41	0.3	0.07	0.4	0.25	0.39	0.49	0.42	0.18	0.08	0.13		0.07	0.15	0.13	0.15	0.04	0.22	0.24	0.05
Good Will	0.94	0.22	0.87	0.96	0.98	0.97	0.86	0.9	0.95	0.81	0.85	0.83	0.07	0.86	0.98	0.95	0.95	0.07		0.86	-0.76	0.89	0.81	0.92	0.8	0.95
Net Tangible Assets	0.91	0.44	0.82	0.93	0.82	0.91	0.84	0.91	0.86	0.85	0.89	0.89	0.24	0.81	0.85	0.91	0.91	0.15	0.86		-0.7	0.94	0.92	0.98	0.94	0.92
Deferred Long Term Liab	-0.75	-0.13	-0.7	-0.77	-0.67	-0.79	-0.66	-0.69	-0.78	-0.61	-0.74	-0.67	0.07	-0.65	-0.72	-0.82	-0.81	0.13	-0.76	-0.7		-0.72	-0.8	-0.69	-0.62	-0.71
Long Term Investments	0.9	0.28	0.82	0.92	0.86	0.89	0.85	0.88	0.82	0.85	0.92	0.88	0.12	0.81	0.87	0.94	0.89	0.15	0.89	0.94	-0.72		0.83	0.95	0.93	0.9
Short Long Term Debt	0.84	0.55	0.76	0.86	0.75	0.84	0.74	0.83	0.82	0.78	0.83	0.83	0.29	0.74	0.75	0.87	0.86	0.04	0.81	0.92	-0.8	0.83		0.86	0.88	0.83
Total Current Assets	0.95	0.36	0.86	0.97	0.9	0.95	0.89	0.94	0.9	0.87	0.91	0.9	0.19	0.86	0.93	0.93	0.94	0.22	0.92	0.98	-0.69	0.95	0.86		0.91	0.95
Short Term Debt	0.84	0.51	0.76	0.85	0.75	0.8	0.81	0.84	0.71	0.86	0.88	0.9	0.36	0.77	0.76	0.87	0.82	0.24	0.8	0.94	-0.62	0.93	0.88	0.91		0.81
Non Current Assets Total	0.91	0.3	0.83	0.92	0.92	0.94	0.81	0.87	0.93	0.76	0.8	0.79	0.13	0.82	0.93	0.9	0.92	0.05	0.95	0.92	-0.71	0.9	0.83	0.95	0.81

Click cells to compare fundamentals

Huadong Medicine Account Relationship Matchups

Huadong Medicine fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	21.5B	24.2B	27.0B	31.2B	33.5B	35.2B
Other Current Liab	1.4B	1.8B	2.0B	2.3B	16.0M	15.2M
Total Current Liabilities	8.4B	8.6B	9.3B	10.2B	10.8B	11.3B
Total Stockholder Equity	12.3B	14.6B	16.6B	18.6B	21.0B	22.1B
Other Liab	397.3M	200.7M	236.6M	569.4M	654.8M	687.6M
Retained Earnings	8.4B	10.7B	12.6B	13.5B	15.7B	16.5B
Accounts Payable	4.4B	4.5B	4.5B	5.9B	6.1B	6.4B
Cash	2.4B	3.2B	4.0B	4.0B	4.7B	4.9B
Other Assets	356.7M	334.3M	876.5M	1.1B	1.2B	1.3B
Net Receivables	6.9B	6.1B	7.2B	7.2B	7.5B	7.8B
Inventory	4.0B	4.1B	4.0B	4.5B	4.3B	4.5B
Other Current Assets	425.7M	336.2M	316.0M	582.3M	59.9M	56.9M
Total Liab	8.6B	9.0B	10.1B	12.0B	11.9B	12.5B
Intangible Assets	1.5B	1.5B	2.2B	2.9B	3.3B	3.5B
Property Plant Equipment	4.0B	4.7B	4.8B	5.0B	5.8B	6.1B
Long Term Debt	48.1M	151.6M	139.2M	1.1B	520.8M	489.6M
Net Tangible Assets	7.0B	9.4B	11.7B	12.2B	14.0B	9.0B
Deferred Long Term Liab	12.5M	12.3M	8.8M	12.4M	11.2M	10.1M
Short Long Term Debt	655.5M	1.4B	1.2B	947.5M	822.4M	808.2M
Total Current Assets	13.7B	14.7B	15.5B	17.6B	18.5B	15.5B
Non Current Assets Total	7.7B	9.5B	11.5B	13.6B	15.0B	9.6B
Non Currrent Assets Other	184.1M	712.1M	911.1M	1.0B	1.6B	1.6B
Non Current Liabilities Total	200.7M	388.3M	789.5M	1.9B	1.1B	1.1B
Non Current Liabilities Other	52.1M	39.5M	39.1M	111.2M	84.4M	80.1M
Net Invested Capital	13.0B	16.2B	18.0B	20.6B	22.4B	17.5B
Net Working Capital	5.3B	6.0B	6.2B	7.4B	7.7B	7.1B
Other Stockholder Equity	22.8M	(2.2M)	(47.8M)	(88.6M)	(79.7M)	(75.7M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Huadong Stock

Balance Sheet is a snapshot of the financial position of Huadong Medicine at a specified time, usually calculated after every quarter, six months, or one year. Huadong Medicine Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Huadong Medicine and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Huadong currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Huadong Operating Income vs Gross Profit Analysis

Operating Income vs Gross Profit

Operating Income vs Gross Profit Correlation Analysis

Correlation Coefficient

Operating Income

Gross Profit

Huadong Medicine fundamental ratios Correlations

Huadong Medicine Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Huadong Medicine fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Huadong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Retained Earnings	+ 0.99	Total Stockholder Equity
Property Plant Equipment	+ 0.99	Total Stockholder Equity
Property Plant Equipment	+ 0.99	Retained Earnings

Deferred Long Term Liab	- 0.82	Common Stock
Deferred Long Term Liab	- 0.81	Property Plant Equipment
Short Long Term Debt	- 0.8	Deferred Long Term Liab
Deferred Long Term Liab	- 0.79	Retained Earnings
Deferred Long Term Liab	- 0.78	Other Assets
Deferred Long Term Liab	- 0.77	Total Stockholder Equity